Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MIR-155: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | MIR-155 |
| Key Genes/Proteins | ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AND, APOE, AXIN1 |
| Related Diseases | Aging, Als, ALS, Alzheimer |
| Related Pathways | Amyloid |
graph TD
MIR_155["MIR-155"]
MIR_155 -->|"promotes"| vascular_inflammation["vascular inflammation"]
MIR_155 -->|"binds_to"| IRF2BP2["IRF2BP2"]
MIR_155 -->|"promotes"| IL_6["IL-6"]
MIR_155 -->|"expressed in"| Als["Als"]
MIR_155 -->|"activates"| Alzheimer["Alzheimer"]
MIR_155 -->|"activates"| Aging["Aging"]
MIR_155 -->|"activates"| Neurodegeneration["Neurodegeneration"]
MECP2["MECP2"] -->|"target for"| MIR_155
MICRORNAS["MICRORNAS"] -->|"expressed in"| MIR_155
CLEC7A["CLEC7A"] -->|"activates"| MIR_155
AMYLOID["AMYLOID"] -->|"activates"| MIR_155
ALZHEIMER["ALZHEIMER"] -->|"activates"| MIR_155
RNA["RNA"] -->|"activates"| MIR_155
MICROGLIA["MICROGLIA"] -->|"activates"| MIR_155
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| MIR_155| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:MIR-155 | data_in | dataset_row | 0.00 |
| h-42f8fa19eb | targeted_by | hypothesis | 1.00 |
| vascular inflammation | promotes | process | 0.93 |
| Poor Outcomes | associated_with | phenotype | 0.90 |
| Increased Mortality | associated_with | phenotype | 0.90 |
| IRF2BP2 | binds_to | gene | 0.90 |
| psoriasis | associated_with | disease | 0.85 |
| IL-6 | promotes | protein | 0.85 |
| Neuroinflammation | upregulates | process | 0.85 |
| Als | expressed_in | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| TBP | activates | gene | 0.60 |
| Amyloid | regulates | pathway | 0.60 |
| AND | expressed_in | gene | 0.60 |
| MICRORNAS | expressed_in | gene | 0.60 |
| MECP2 | expressed_in | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| NTRK2 | expressed_in | gene | 0.60 |
| MICRORNAS | associated_with | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| AMYLOID | activates | gene | 0.60 |
| TREM2 | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| Amyloid | activates | pathway | 0.60 |
| MIRNAS | associated_with | gene | 0.60 |
| MECP2 | therapeutic_target | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| CLEC7A | activates | gene | 0.60 |
| Rb | associated_with | protein | 0.60 |
| Ras | therapeutic_target | protein | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| Microglia | activates | cell_type | 0.60 |
| Phagocytosis | activates | pathway | 0.60 |
| EGR1 | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| HNF4A | activates | gene | 0.60 |
| CCND1 | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| MYC | activates | gene | 0.60 |
| YWHAZ | activates | gene | 0.60 |
| TXNIP | activates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| SOCS3 | activates | gene | 0.60 |
| RELA | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:MIR-155 | data_in | dataset_row | 0.00 |
| h-42f8fa19eb | targets | hypothesis | 1.00 |
| MICRORNAS | associated_with | gene | 0.70 |
| MIRNAS | associated_with | gene | 0.60 |
| CLEC7A | activates | gene | 0.60 |
| AMYLOID | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| STAT1 | activates | gene | 0.60 |
| MYH9 | activates | gene | 0.60 |
| HUB GENES | regulates | gene | 0.60 |
| AMYLOID | regulates | gene | 0.60 |
| AXIN1 | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| MIRNAS | activates | gene | 0.60 |
| MICRORNAS | regulates | gene | 0.60 |
| RHEB | activates | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| CREB1 | expressed_in | gene | 0.60 |
| MEF2C | expressed_in | gene | 0.60 |
| GAIN | regulates | gene | 0.60 |
| DGKQ | expressed_in | gene | 0.60 |
| PDE4B | expressed_in | gene | 0.60 |
| BDNF | expressed_in | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| SPI1 | activates | gene | 0.60 |
| SOCS3 | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| TBP | activates | gene | 0.60 |
| MYC | activates | gene | 0.60 |
| HNF4A | activates | gene | 0.60 |
| YWHAZ | activates | gene | 0.60 |
| RELA | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| TXNIP | activates | gene | 0.60 |
| EGR1 | activates | gene | 0.60 |
| CCND1 | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| MECP2 | therapeutic_target | gene | 0.60 |
| MICRORNAS | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| miR-155/Interferon-gamma Feedback Loop as a Reversible Molec | 0.843 | neurodegeneration | How do different microglial subtypes (DA |
| Age-Accelerated miR-155 Upregulation Primes Nigral Microglia | 0.610 | neuroinflammation | How do regional, age, and sex-dependent |
| CX3CR1-Targeted AntimiR-155 Oligonucleotides for Microglial | 0.530 | pharmacology | How can CNS-selective HDAC/DNMT inhibito |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Changes in Circulating Levels of miR-30b During Minipuberty and Puberty in Girls [PMID:40899010] | Albrechtsen HM, Saritas G, Winge SB, Mai | J Clin Endocrinol Metab | 2026 | 0 |
| Epigenetics in chronic rhinosinusitis. [PMID:41442742] | Kumar N, Brar T, Lal D | Curr Opin Otolaryngol Head Nec | 2026 | 0 |
| Extracellular vesicles in type 2 diabetes exhibit elevated miR-155 cargo and Ann [PMID:41786286] | Jackson G, Islam H, de Souza Teixeira AA | Life Sci | 2026 | 0 |
| Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular [PMID:41918207] | Mishra R, Gupta JK | Curr Alzheimer Res | 2026 | 0 |
| Di-2-ethylhexylphthalate-induced miR155-5P promotes placental ferroptosis. [PMID:41937013] | Gu X, Sun F, Li Y, Yang S, Li Y | Int J Biol Macromol | 2026 | 0 |
| Extracellular Vesicles in Obesity: From Pathophysiological Mediators to Therapeu [PMID:41977323] | Pavlović N, Todorović P, Maglica M, Kopi | Int J Mol Sci | 2026 | 0 |
| Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular [PMID:41918207] | Mishra R, Gupta JK | Current Alzheimer research | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning MIR-155 in their description or question text
No additional research found